These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 36563698)

  • 1. Lung cancer screening.
    Adams SJ; Stone E; Baldwin DR; Vliegenthart R; Lee P; Fintelmann FJ
    Lancet; 2023 Feb; 401(10374):390-408. PubMed ID: 36563698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose computed tomography lung cancer screening: Clinical evidence and implementation research.
    Lancaster HL; Heuvelmans MA; Oudkerk M
    J Intern Med; 2022 Jul; 292(1):68-80. PubMed ID: 35253286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
    Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
    Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and Future Perspectives on Computed Tomography Screening for Lung Cancer: A Roadmap From 2023 to 2027 From the International Association for the Study of Lung Cancer.
    Lam S; Bai C; Baldwin DR; Chen Y; Connolly C; de Koning H; Heuvelmans MA; Hu P; Kazerooni EA; Lancaster HL; Langs G; McWilliams A; Osarogiagbon RU; Oudkerk M; Peters M; Robbins HA; Sahar L; Smith RA; Triphuridet N; Field J
    J Thorac Oncol; 2024 Jan; 19(1):36-51. PubMed ID: 37487906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trade-off between benefits, harms and economic efficiency of low-dose CT lung cancer screening: a microsimulation analysis of nodule management strategies in a population-based setting.
    Treskova M; Aumann I; Golpon H; Vogel-Claussen J; Welte T; Kuhlmann A
    BMC Med; 2017 Aug; 15(1):162. PubMed ID: 28838313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial Intelligence and Machine Learning in Lung Cancer Screening.
    Adams SJ; Mikhael P; Wohlwend J; Barzilay R; Sequist LV; Fintelmann FJ
    Thorac Surg Clin; 2023 Nov; 33(4):401-409. PubMed ID: 37806742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of implementing computed tomography screening for lung cancer in Taiwan.
    Yang SC; Lai WW; Lin CC; Su WC; Ku LJ; Hwang JS; Wang JD
    Lung Cancer; 2017 Jun; 108():183-191. PubMed ID: 28625633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung cancer screening implementation: Complexities and priorities.
    Rankin NM; McWilliams A; Marshall HM
    Respirology; 2020 Nov; 25 Suppl 2():5-23. PubMed ID: 33200529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung CAncer SCreening in French women using low-dose CT and Artificial intelligence for DEtection: the CASCADE study protocol.
    Revel MP; Abdoul H; Chassagnon G; Canniff E; Durand-Zaleski I; Wislez M
    BMJ Open; 2022 Dec; 12(12):e067263. PubMed ID: 36600392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary issues in the implementation of lung cancer screening.
    Lam S; Tammemagi M
    Eur Respir Rev; 2021 Sep; 30(161):. PubMed ID: 34289983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of risk prediction models to lung cancer screening: a review.
    Tammemägi MC
    J Thorac Imaging; 2015 Mar; 30(2):88-100. PubMed ID: 25692785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the Cost-Effectiveness of Lung Cancer Screening with Low-Dose Computed Tomography for High-Risk Smokers in Australia.
    Wade S; Weber M; Caruana M; Kang YJ; Marshall H; Manser R; Vinod S; Rankin N; Fong K; Canfell K
    J Thorac Oncol; 2018 Aug; 13(8):1094-1105. PubMed ID: 29689434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Reduced' HUNT model outperforms NLST and NELSON study criteria in predicting lung cancer in the Danish screening trial.
    Røe OD; Markaki M; Tsamardinos I; Lagani V; Nguyen OTD; Pedersen JH; Saghir Z; Ashraf HG
    BMJ Open Respir Res; 2019; 6(1):e000512. PubMed ID: 31803478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk-Targeted Lung Cancer Screening: A Cost-Effectiveness Analysis.
    Kumar V; Cohen JT; van Klaveren D; Soeteman DI; Wong JB; Neumann PJ; Kent DM
    Ann Intern Med; 2018 Feb; 168(3):161-169. PubMed ID: 29297005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Jonas DE; Reuland DS; Reddy SM; Nagle M; Clark SD; Weber RP; Enyioha C; Malo TL; Brenner AT; Armstrong C; Coker-Schwimmer M; Middleton JC; Voisin C; Harris RP
    JAMA; 2021 Mar; 325(10):971-987. PubMed ID: 33687468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moving beyond the national lung screening trial: discussing strategies for implementation of lung cancer screening programs.
    Goulart BH; Ramsey SD
    Oncologist; 2013; 18(8):941-6. PubMed ID: 23873718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.
    Horeweg N; Scholten ET; de Jong PA; van der Aalst CM; Weenink C; Lammers JW; Nackaerts K; Vliegenthart R; ten Haaf K; Yousaf-Khan UA; Heuvelmans MA; Thunnissen E; Oudkerk M; Mali W; de Koning HJ
    Lancet Oncol; 2014 Nov; 15(12):1342-50. PubMed ID: 25282284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computed tomography screening for lung cancer in the National Lung Screening Trial: a cost-effectiveness analysis.
    Black WC
    J Thorac Imaging; 2015 Mar; 30(2):79-87. PubMed ID: 25635704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung cancer screening and management.
    Jones GS; Baldwin DR
    Minerva Med; 2015 Dec; 106(6):339-54. PubMed ID: 26605556
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.